LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.05% | 5.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.05% | 5.36% | |||
| Cost of Revenue | 3.51% | 4.37% | |||
| Gross Profit | 8.33% | 7.52% | |||
| SG&A Expenses | -0.99% | -1.73% | |||
| Depreciation & Amortization | -0.91% | -3.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.13% | 2.36% | |||
| Operating Income | 147.04% | 348.61% | |||
| Income Before Tax | 232.52% | 176.94% | |||
| Income Tax Expenses | 1.14% | 262.48% | |||
| Earnings from Continuing Operations | 983.38% | 128.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 983.38% | 128.41% | |||
| EBIT | 147.04% | 348.61% | |||
| EBITDA | 51.03% | 88.96% | |||
| EPS Basic | 975.00% | 128.57% | |||
| Normalized Basic EPS | 236.99% | 176.04% | |||
| EPS Diluted | 953.57% | 128.00% | |||
| Normalized Diluted EPS | 233.33% | 175.00% | |||
| Average Basic Shares Outstanding | 0.01% | 0.06% | |||
| Average Diluted Shares Outstanding | 1.83% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||